Secondary malignant neoplasm of right adrenal gland
ICD-10 C79.71 is a billable code used to indicate a diagnosis of secondary malignant neoplasm of right adrenal gland.
C79.71 refers to a secondary malignant neoplasm located in the right adrenal gland, indicating that the cancer has metastasized from a primary site elsewhere in the body. This condition is characterized by the presence of malignant cells in the adrenal gland, which can disrupt normal adrenal function and lead to various systemic symptoms. The adrenal glands are responsible for producing hormones that regulate metabolism, immune response, and stress reactions. Metastatic disease to the adrenal glands is often a sign of advanced cancer, and the primary tumor may be unknown at the time of diagnosis. Common primary sites include lung, breast, and kidney cancers. Staging of metastatic disease is crucial for determining prognosis and treatment options, which may include systemic therapies, radiation, or palliative care. Palliative care considerations are essential, as patients may experience significant symptoms related to both the cancer and its treatment, necessitating a multidisciplinary approach to manage pain and improve quality of life.
Detailed documentation of the primary cancer site, staging, and treatment plans.
Patients with known primary cancers presenting with adrenal masses.
Ensure that the metastatic nature is clearly documented to avoid misclassification.
Hormonal assessment results and any functional implications of the adrenal metastasis.
Patients presenting with adrenal insufficiency or hormonal imbalances due to metastatic disease.
Document any endocrine dysfunctions resulting from the neoplasm.
Used to evaluate adrenal masses in patients with known malignancies.
Document indication for imaging and findings related to the adrenal gland.
Oncology specialists should ensure imaging correlates with clinical findings.
Identifying the primary cancer site is crucial for accurate staging, treatment planning, and prognosis. It also ensures proper coding and billing, as secondary neoplasms are often linked to specific primary cancers.
